α-Synuclein expression is modulated at the translational level by iron

NeuroReport

Volumn 23, Issue 9, 2012, Pages 576-580

  Febbraro, Fabia ^a   Giorgi, Marcello ^b   Caldarola, Sara ^b   Loreni, Fabrizio ^b   Romero Ramos, Marina ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

deferoxamine; HEK293; iron responsive element; Parkinson's disease; polysomes

Indexed keywords

ALPHA SYNUCLEIN; DEFEROXAMINE; FERRIC AMMONIUM CITRATE; FERRITIN; MESSENGER RNA; TRANSFERRIN RECEPTOR;

5' UNTRANSLATED REGION; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; HUMAN; HUMAN CELL; IRON CHELATION; IRON DEFICIENCY; IRON RESPONSIVE ELEMENT; LEWY BODY; PARKINSON DISEASE; POLYSOME; POST MORTEM MYOLIQUEFACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SUBSTANTIA NIGRA;

ALPHA-SYNUCLEIN; ANIMALS; BRAIN; CELLS, CULTURED; DEFEROXAMINE; FERRIC COMPOUNDS; HEK293 CELLS; HUMANS; IRON; KIDNEY; LEWY BODIES; PARKINSON DISEASE; PROTEIN BIOSYNTHESIS; QUATERNARY AMMONIUM COMPOUNDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RODENTIA; SIDEROPHORES;

EID: 84861453955     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328354a1f0     Document Type: Article

References (24)

1. Lee DW, Andersen JK; Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis? J Neurochem; 2010; 112: 332-339
2. Borie C, Gasparini F, Verpillat P, Bonnet AM, Agid Y, Hetet G, et al Association study between iron-related genes polymorphisms and Parkinson's disease J Neurol 2002; 249:801-804 (Pubitemid 34754212)
3. Schneider BD, Leibold EA Effects of iron regulatory protein regulation on iron homeostasis during hypoxia Blood 2003; 102:3404-3411 (Pubitemid 37314783)
4. Abraham Mazur SG, Carleton A Mechanism of Plasma Iron Incorporation into Hepatic Ferritin J Biol Chem 1959; 235:595-603
5. Hohnholt M, Geppert M, Dringen R Effects of iron chelators, iron salts, and iron oxide nanoparticles on the proliferation and the iron content of oligodendroglial OLN-93 cells Neurochem Res 2010; 35:1259-1268
6. Hoepken HH, Korten T, Robinson SR, Dringen R Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate J Neurochem 2004; 88:1194-1202 (Pubitemid 38280687)
7. Martin WR, Wieler M, Gee M Midbrain iron content in early Parkinson disease: a potential biomarker of disease status Neurology 2008; 70:1411-1417 (Pubitemid 351521933)
8. Li WJ, Jiang H, Song N, Xie JX Dose- and time-dependent alpha-synuclein aggregation induced by ferric iron in SK-N-SH cells Neurosci Bull 2010; 26:205-210
9. Davies P, Moualla D, Brown DR Alpha-synuclein is a cellular ferrireductase PLoS One 2011; 6:1-7
10. Friedlich AL, Tanzi RE, Rogers JT The 50-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element Mol Psychiatry 2007; 12:222-223 (Pubitemid 46328508)
11. Rouault TA The role of iron regulatory proteins in mammalian iron homeostasis and disease Nat Chem Biol 2006; 2:406-414 (Pubitemid 44114917)
12. Rogers JT, Mikkilineni S, Cantuti-Castelvetri I, Smith DH, Huang X, Bandyopadhyay S, et al The alpha-synuclein 50untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen J Neural Transm 2011; 118:493-507
13. Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, et al An iron-responsive element type II in the 50-untranslated region of the Alzheimer's amyloid precursor protein transcript J Biol Chem 2002; 277:45518-45528 (Pubitemid 36159162)
14. Maroteaux L, Scheller RH The rat brain synucleins; family of proteins transiently associated with neuronal membrane Brain Res Mol Brain Res 1991; 11:335-343
15. Olivares D, Huang X, Branden L, Greig NH, Rogers JT Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element Int J Mol Sci 2009; 10:1226-1260
16. Ueda K, Saitoh T, Mori H Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid Biochem Biophys Res Commun 1994; 205:1366-1372
17. Li W, Jiang H, Song N, Xie J Oxidative stress partially contributes to ironinduced alpha-synuclein aggregation in SK-N-SH cells Neurotox Res 2011; 19:435-442
18. Cole NB, Murphy DD, Lebowitz J, Di Noto L, Levine RL, Nussbaum RL Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments J Biol Chem 2005; 280:9678-9690 (Pubitemid 40409666)
19. Golts N, Snyder H, Frasier M, Theisler C, Choi P, Wolozin B Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein J Biol Chem 2002; 277:16116-16123 (Pubitemid 34967897)
20. Gotz ME, Double K, Gerlach M, Youdim MB, Riederer P The relevance of iron in the pathogenesis of Parkinson's disease Ann N Y Acad Sci 2004; 1012:193-208 (Pubitemid 38455479)
21. Hashimoto M, Takeda A, Hsu LJ, Takenouchi T, Masliah E Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease J Biol Chem 1999; 274:28849-28852
22. Sangchot P, Sharma S, Chetsawang B, Porter J, Govitrapong P, Ebadi M Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alpha-synuclein translocation in SK-N-SH cells in culture Dev Neurosci 2002; 24:143-153 (Pubitemid 36151444)
23. Fernaeus S, Halldin J, Bedecs K, Land T Changed iron regulation in scrapieinfected neuroblastoma cells Brain Res Mol Brain Res 2005; 133:266-273 (Pubitemid 40248416)
24. Wiesinger JA, Buwen JP, Cifelli CJ, Unger EL, Jones BC, Beard JL Downregulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis J Neurochem 2007; 100:167-179. (Pubitemid 46085847)